Background Device-related thrombus (DRT) has been considered an Achilles' heel of left
atrial appendage occlusion (LAAO). However, data on DRT prediction remain limited …

Objectives This study sought to report early experience with the new-generation Watchman
FLX device (Boston Scientific, Marlborough, Massachusetts). Background The new …

Transcatheter interventions enable safe and efficient treatment of various structural heart
diseases. However, therapy does not finished with the end of the procedure. Device …

Atrial fibrillation (AF) is the most common arrhythmia worldwide and is associated with
increased risk of heart failure, stroke, and death. In current medical practice, multimodality …

Introduction The Watchman FLX is a novel device for transcatheter left atrial appendage
occlusion (LAAO) specifically designed to improve procedural performance in more complex …

SHORTCOMMUNICATION Watchman FLX: initial Polish experience 241 adverse events,
including stroke or severe bleed‑ing. The position of the device was unchanged in all …

The thromboembolic complications of Atrial fibrillation (AF) remain a major problem in
contemporary clinical practice. Despite advances and developments in anticoagulation …

Atrial fibrillation (AF) is the most common arrhythmia worldwide, and is associated with a
significant risk of thromboembolic events. Left atrial appendage occlusion (LAAO) has …

Since the first percutaneous left atrial appendage occlusion (LAAO), many studies have
shown the safety and efficacy of this technique to prevent embolic strokes in nonvavular …

In the assessment of cardiovascular disease, the clinical significance of left atrial (LA)
pressure-volume relations has largely been overlooked in contrast to left ventricular (LV) …